FDA Warning Letter — Osteolife Biomedical I LLC
The FDA took a Warning Letter action against Osteolife Biomedical I LLC on March 31, 2022 (Miami, FL). The action was issued by CBER and concerns biologics products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Osteolife Biomedical I LLC
- Date
- March 31, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Center
- CBER
- Location
- Miami, FL (United States)